Sputtr.com | Alternative Search Engine

Victoza

WARNINGS AND PRECAUTIONS ———

Victoza should be used with caution in this patient population. No dose adjustment of Victoza is recommended for patients with renal impairment [see

Victoza (liraglutide [rDNA origin] injection

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Victoza safely and effectively. See full prescribing information for Victoza.

These highlights do not include all the information needed to ...

These highlights do not include all the information needed to use Victoza safely and effectively. See full prescribing information for Victoza.VictozaVictoza Medication Guide

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER Victoza 6 mg/ml solution for injection in pre-filled pen Liraglutide Read all of this leaflet carefully before you start using this medicine.

instructions for use

Pen cap Flow check symbol Protective tab Needle Inner needle cap Outer needle cap Victoza ® Pen Needle (example) If you have already used your Pen, follow these steps If this is the first time with a new Pen, follow these steps After setting up a new Pen, follow these steps Preparing Your Pen ...

Patient Assistance Program

Victoza ® is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) (5.1).

IMPORTANT DRUG WARNING CONCERNING VICTOZA

important drug warning concerning victoza ® subject: potential risks of thyroid c-cell tumors and acute pancreatitis associated with victoza

Byetta® (exenatide), Victoza®

Page 1 of 2 A claim involving "urgent care" applies when then standard review time will seriously jeopardize the life or health of the member, or subject the member to severe pain that cannot be managed without the care or treatment requested in the subject of this request.

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Victoza ▼ 6 mg/ml solution for injection in pre-filled pen 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 6 mg of liraglutide*.

Victoza

2 . Lars Rebien Sørensen . President and CEO, Novo Nordisk Share • May 2010